{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.4","value":"-7.5"},{"groupId":"OG001","spread":"11.0","value":"3.4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"description":"Quality of life will be measured on the 27-item Functional Assessment of Cancer Therapy-General (FACT-G) including 26 summed items (responses 0 to 4 to equal a possible total score 0-108). Higher scores represent better quality of life. Average change in Quality of Life scores from baseline to end of study will be reported for each separate arm","dispersionType":"Standard Deviation","groups":[{"description":"Patients receive glutamine PO BID. Courses repeat every 28 days for 4 months in the absence of disease progression or unacceptable toxicity.\n\nglutamine: Dose of 15 grams twice times daily (to equal 30 grams a day) for a period of 4 months.\n\nquality-of-life assessment: Ancillary studies","id":"OG000","title":"Arm I (Preventative Nutritional Supplementation)"},{"description":"Patients receive placebo PO BID. Courses repeat every 28 days for 4 months in the absence of disease progression or unacceptable toxicity.\n\nquality-of-life assessment: Ancillary studies\n\nplacebo: Given PO","id":"OG001","title":"Arm II (Placebo)"}],"paramType":"MEAN","populationDescription":"All participants enrolled in study and given treatment.","reportingStatus":"POSTED","timeFrame":"from baseline to end of study at 4 months","title":"Average Change in Quality of Life Scores From Baseline to End of Study","type":"SECONDARY","unitOfMeasure":"score on a scale"}